Showing results (1271-1280 of 1,437) with videos related to

Sort By:
Pageof 144
Nature Immunology|January 12, 2021
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformationMartín A Rivas, Cem Meydan, Christopher R Chin, et al.
Cancer Cell|July 5, 2011
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformationKelly Moran-Crusio, Linsey Reavie, Alan Shih, et al.
Life (Basel, Switzerland)|March 25, 2022
Biomarkers of Animal Nutrition: From Seasonal to Lifetime Indicators of Environmental ConditionsRachel A Smiley, Tayler N LaSharr, Heather N Abernathy, et al.
Cancer Cell|December 11, 2007
Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate allelesStefan Fröhling, Claudia Scholl, Ross L Levine, et al.
Blood|May 4, 2013
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemiaCourtney D DiNardo, Kathleen J Propert, Alison W Loren, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Cancer Discovery|June 12, 2012
Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependentRita Andraos, Zhiyan Qian, Débora Bonenfant, et al.
Blood|November 30, 2016
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelHartmut Döhner, Elihu Estey, David Grimwade, et al.
Leukemia Research|October 30, 2012
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosisAdi Diab, Lynette Zickl, Omar Abdel-Wahab, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancerNancy M Hardy, Miriam E Mossoba, Seth M Steinberg, et al.
Pageof 144